Alfred Altomari is CEO at AGILE THERAPEUTICS INC (AGRX). They have made 21 open-market trades across 6 companies since 2007, most recently 2024-08-26.
CIK 0001285644
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
15 open-market purchases totalling $334K since 2010, against 6 sales. Across 13 scored buys the stock is up 0.7% at ninety days, and 4.8 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 38% | 54% |
| Avg Move | -2.8% | -2.4% | +0.7% |
| Alpha | -4.1% | -3.9% | -4.8% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGRX | BUY | 2022-08-26 | 2022-08-29 | $0.45 | $23K | -6.4% | -31.4% | -53.5% |
| AGRX | BUY | 2021-07-29 | 2021-07-29 | $1.26 | $33K | -11.2% | -5.6% | -37.4% |
| AGRX | BUY | 2021-05-18 | 2021-05-19 | $1.61 | $32K | -1.8% | -15.1% | -42.6% |
| AGRX | BUY | 2021-03-23 | 2021-03-23 | $2.00 | $25K | -1.4% | -12.4% | -35.4% |
| INSM | SELL | 2020-12-07 | 2020-12-09 | $39.57 | $791K | -7.4% | -15.7% | +0.0% |
| BXRX | BUY | 2020-11-23 | 2020-11-24 | $1.06 | $5K | +1.8% | -6.3% | +38.4% |
| BXRX | BUY | 2020-03-26 | 2020-03-27 | $2.34 | $12K | -12.7% | +13.8% | +56.0% |
| AGRX | BUY | 2020-02-27 | 2020-02-27 | $2.71 | $27K | -15.3% | -13.7% | +28.1% |
| AGRX | BUY | 2019-06-10 | 2019-06-11 | $1.27 | $25K | +8.2% | +4.5% | +1.5% |
| AGRX | BUY | 2019-03-25 | 2019-03-26 | $1.54 | $39K | +0.7% | +0.0% | -4.7% |
| INSM | SELL | 2019-02-26 | 2019-02-27 | $30.00 | $165K | +2.6% | -2.8% | -14.4% |
| INSM | SELL | 2019-02-15 | 2019-02-20 | $27.50 | $151K | +15.8% | +9.8% | +2.8% |
| INSM | SELL | 2019-02-05 | 2019-02-07 | $25.00 | $138K | +6.5% | +25.5% | +16.3% |
| INSM | SELL | 2019-01-10 | 2019-01-14 | $22.50 | $124K | +11.0% | +16.5% | +41.1% |
| AGRX | BUY | 2017-08-25 | 2017-08-28 | $3.34 | $33K | +4.5% | +29.5% | +54.2% |
| AGRX | BUY | 2017-05-11 | 2017-05-12 | $3.51 | $35K | -0.9% | +5.7% | -6.8% |
| REPH | BUY | 2016-12-15 | 2016-12-16 | $6.55 | $10K | +14.9% | -1.1% | +11.0% |
| AGRX | BUY | 2015-06-02 | 2015-06-03 | $8.73 | $22K | -16.6% | +0.2% | +0.2% |
| DUSA | BUY | 2011-08-11 | 2011-08-11 | $4.06 | $8K | N/A | N/A | N/A |
| DUSA | BUY | 2010-08-05 | 2010-08-05 | $2.52 | $5K | N/A | N/A | N/A |
| AUXL | SELL | 2007-05-08 | 2007-05-10 | $13.33 | $200K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $6.8M |
Shares reported on the most recent Form 4, priced at the 2024-08-26 close. 3 holdings could not be priced and are excluded from the total.